Product NDC: | 0172-5313 |
Proprietary Name: | Ciprofloxacin Hydrochloride |
Non Proprietary Name: | Ciprofloxacin Hydrochloride |
Active Ingredient(s): | 750 mg/1 & nbsp; Ciprofloxacin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0172-5313 |
Labeler Name: | Ivax Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076089 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040609 |
Package NDC: | 0172-5313-10 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0172-5313-10) > 1 TABLET in 1 BLISTER PACK (0172-5313-00) |
NDC Code | 0172-5313-10 |
Proprietary Name | Ciprofloxacin Hydrochloride |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0172-5313-10) > 1 TABLET in 1 BLISTER PACK (0172-5313-00) |
Product NDC | 0172-5313 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ciprofloxacin Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040609 |
Marketing Category Name | ANDA |
Labeler Name | Ivax Pharmaceuticals Inc. |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | 750 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |